The decision to test with PanTum Detect is a personal one for every individual.
The individual needs to be aware of the limitations and should weigh these against the benefits of annual screening with PanTum Detect.
BENEFITS
PanTum Detect is a simple blood test for immune cells analysis for early warning signals covering 200+ cancer sites.
PanTum Detect has an EU-IVDR labeled sensitivity of 82% (true positives) and specificity of 99% (true negatives).
PanTum Detect is suitable for preventive cancer health check and offers screened candidates protection from risk of delay in detection of 200+ cancer sites.
Annual screening increases for 200+ cancer sites reduces preventable cancer deaths and increases the chance of detecting a silently growing tumor in early localized stage/s.
Only those screened candidates who test positive with PanTum Detect are exposed to standard protocols for early-stage cancer detection adavnced pathology & imaging diagnostics.
Financial sponsors obtain documented evidence of limiting cost per cancer event to maximum of ₹2 to 5 lakhs reducing cancer risk to avail adequate “group” health cover at lower insurance premiums.
LIMITATIONS
PanTum Detect is not suitable for individuals with a compromised immune system which negatively influences circulating macrophage numbers.
No screening test provides a result that is 100% accurate or reliable.
As per EU-IVDR approved instruction for use (IFU):
Specificity of 99% means statistically 1% (1 in 100) candidates will receive a false positive result (they don’t have the disease but test positive).
Sensitivity of 82% means statistically 18%(18 in 100) candidates with disease will receive a false negative result (they do have malignant tumor growth but test negative).
Psychological strain of false positive results for healthy individuals screened annually with PanTum Detect needs to be considered alongside benefits of timely detection of all solid organ cancer types within the critical detection time window that significantly increases survival rates and reduces treatment complexity and medical costs/insurance claims.